Bio-Techne (NASDAQ:TECH)oration is a life sciences company that develops and supplies research, diagnostic and bioprocessing products for the biotechnology and pharmaceutical industries, academic institutions, clinical laboratories and other healthcare organizations. Its portfolio supports research in areas such as cancer, immunology, neuroscience, cell biology and precision medicine.
The company provides proteins, antibodies, immunoassays, reagents, gene and cell therapy materials, and analytical instruments. Its products are used to study biological processes, identify and validate disease biomarkers, develop and manufacture biopharmaceuticals, and support laboratory testing. Bio-Techne also offers technologies for spatial biology, single-cell analysis, protein characterization and tissue-based research through brands including R&D Systems, ProteinSimple, Advanced Cell Diagnostics, Tocris and Novus Biologicals.
Bio-Techne was formed in 2014 through the combination of R&D Systems and ProteinSimple, building on R&D Systems' history as a supplier of research reagents and proteins. The company serves customers internationally through operations, distribution networks and commercial activities across North America, Europe, Asia and other global markets.
